Eos SENOLYTIX, Inc.
PrivateLast Round
Private Placement
Mar 26, 2026
Est. Valuation
$119M
Company Overview
Eos SENOLYTIX, Inc. is a biotechnology company that develops gerotherapeutic peptide medicines targeting mitochondrial dysfunction and senescent cells to improve healthspan and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eos SENOLYTIX, Inc. Comparables
Compare Eos SENOLYTIX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciduous Therapeutics | 84% | |
| Cleara Biotech | 81% | |
| Rubedo Life Sciences | 81% | |
Eos SENOLYTIX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 26, 2026 | ||||
| Series A | Feb 26, 2025 |
Eos SENOLYTIX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rapha Capital Management | Series A |
Eos SENOLYTIX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eos SENOLYTIX, Inc.'s valuation, stock price, and market status.